Showing results (31-40 of 222) with videos related to
Sort By:
Pageof 23
Journal of Hypertension|February 22, 2020
Antihypertensive polytherapy in Australia: prevalence of inappropriate combinations, 2013-2018Michael O Falster, Nicholas A Buckley, David Brieger, et al.Thrombosis and Haemostasis|November 13, 2002
Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin/ogenolysis: studies in plasminogen knock-out miceBiao Zeng, David Bruce, Jillian Kril, et al.Thrombosis and Haemostasis|February 28, 2021
Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort StudyScott Hoskin, David Brieger, Vincent Chow, et al.Heart, Lung & Circulation|September 14, 2015
Long-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Regional and Remote HospitalsSradha Kotwal, Isuru Ranasinghe, David Brieger, et al.Future Cardiology|October 7, 2009
Is there potential for antioxidants to enhance thrombolysis therapy in patients with ischemic stroke?Aisling Clare McMahon, Thi Thuy Hong Duong, David Brieger, et al.American Heart Journal|July 25, 2018
Aspirin hypersensitivity in patients with coronary artery disease: linking pathophysiology to clinical practiceSonali R Gnanenthiran, John Yiannikas, Harry C Lowe, et al.International Journal of Environmental Research and Public Health|September 9, 2022
Impact of the "Warning Signs Campaign" on Characteristics of Patients Presenting with Acute Coronary Syndrome (ACS) to HospitalsEleanor Redwood, Karice Hyun, John French, et al.Journal of the American College of Cardiology|August 14, 2015
Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the EvidenceGilles Montalescot, David Brieger, Anthony J Dalby, et al.Internal Medicine Journal|January 19, 2018
Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort studyDavid Brieger, Clara Chow, Janice Gullick, et al.Heart, Lung & Circulation|May 19, 2022
Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian PopulationMingxi Hou, Karice Hyun, Derek P Chew, et al.Pageof 23